DJIA 17,212.18 55.33 0.32%
NASDAQ 4,578.11 15.92 0.35%
S&P 500 2,008.76 7.19 0.36%
market minute promo

Pfizer (NYSE: PFE)

30.48 0.13 (0.43%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $30.48 0.43%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.41
Previous Close $30.35
Daily Range $30.34 - $30.50
52-Week Range $27.87 - $32.96
Market Cap $193.3B
P/E Ratio 19.09
Dividend (Yield) $1.04 (3.4%)
Ex-Dividend Date
Dividend Pay Date
07/30/14
09/03/14
Volume 2,108,600
Average Daily Volume 20,747,936
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks are an important part of a well-rounded portfolio. Yet some high-yielding stocks are better left alone. Here is a look at one top name in healthcare that investors should avoid for the time being.

Phibro Animal Health: Improved Operational Performance, Cheaper Debt Drive Appeal

The 4 Stocks That Boosted the Market

Bullish Two Hundred Day Moving Average Cross - PFE

3 Huge Stocks on Traders' Radars

Actavis Is The Best Bet In The Drug Sector

Pre-Market Most Active for Sep 17, 2014 : PFE, GLW, CSCO, AUXL, AKS, EXC, X, RAX, STX, QQQ, YHOO, E

Pre-Market Most Active for Sep 17, 2014 : PFE, GLW, CSCO, AUXL, AKS, EXC, X, RAX, STX, QQQ, YHOO, ERIC

The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

3 Stocks Reiterated As A Buy: PFE, SLB, DIS

ProQR Therapeutics: Competition, Distance From Clinical Trials Leads Us To Hold Off

See More PFE News...

PFE's Top Competitors

PFE $30.48 (0.43%)
Current stock: PFE
JNJ $106.53 (0.32%)
Current stock: JNJ
ROG $58.06 (-0.41%)
Current stock: ROG
GSK $47.42 (0.68%)
Current stock: GSK